These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9488536)

  • 1. Meta-analysis by the Program on the Surgical Control of the Hyperlipidemias (POSCH) investigators.
    Gould AL; Cariski AT
    Ann Surg; 1998 Feb; 227(2):314-6. PubMed ID: 9488536
    [No Abstract]   [Full Text] [Related]  

  • 2. Gender-based mortality follow-up from the Program on the Surgical Control of the Hyperlipidemias (POSCH) and meta-analysis of lipid intervention trials. Women in POSCH and other lipid trials.
    Buchwald H; Campos CT; Boen JR; Nguyen P; Williams SE; Lau J; Chalmers TC
    Ann Surg; 1996 Oct; 224(4):486-98; discussion 498-500. PubMed ID: 8857853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial assessment of lipid-acting drugs in diabetic patients.
    Steiner G
    Am J Cardiol; 1998 Apr; 81(8A):58F-59F. PubMed ID: 9604911
    [No Abstract]   [Full Text] [Related]  

  • 4. [BECAIT [Bezafibrate Coronary Atherosclerosis Intervention Trial]].
    Yoshino G; Hirano T; Kazumi T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():433-5. PubMed ID: 11347109
    [No Abstract]   [Full Text] [Related]  

  • 5. Women in the POSCH trial. Effects of aggressive cholesterol modification in women with coronary heart disease. The POSCH Group. Program on the Surgical Control of the Hyperlipidemias.
    Buchwald H; Campos CT; Matts JP; Fitch LL; Long JM; Varco RL
    Ann Surg; 1992 Oct; 216(4):389-98; discussion 398-400. PubMed ID: 1417188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion of lipoprotein subfractions among efficacy parameters.
    Superko HR
    Am J Cardiol; 1998 Apr; 81(8A):52F-55F. PubMed ID: 9604909
    [No Abstract]   [Full Text] [Related]  

  • 7. Niacin: a powerful adjunct to other lipid-lowering drugs in reducing plaque progression and acute coronary events.
    Davidson MH
    Curr Atheroscler Rep; 2003 Sep; 5(5):418-22. PubMed ID: 12911853
    [No Abstract]   [Full Text] [Related]  

  • 8. [Probucol].
    Yagyu H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():631-6. PubMed ID: 11347145
    [No Abstract]   [Full Text] [Related]  

  • 9. Program on the Surgical Control of the Hyperlipidemias (POSCH): design and methodology. POSCH Group.
    Buchwald H; Matts JP; Fitch LL; Varco RL; Campbell GS; Pearce M; Yellin A; Smink RD; Sawin HS; Campos CT
    J Clin Epidemiol; 1989; 42(12):1111-27. PubMed ID: 2685177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coronary arteriosclerosis and lipid metabolism (hyperlipemia)].
    Nakamura H
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():69-74. PubMed ID: 12734955
    [No Abstract]   [Full Text] [Related]  

  • 11. The worth of controlling plasma lipids.
    Kannel WB
    Am J Cardiol; 1998 Apr; 81(8):1047-9. PubMed ID: 9576167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia.
    Nakamura T; Kodama Y; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Kitta Y; Kobayashi T; Mende A; Kugiyama K
    Atherosclerosis; 2007 Aug; 193(2):449-51. PubMed ID: 16997309
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence-based management of dyslipidemias in women.
    LaRosa JC
    Curr Atheroscler Rep; 2003 Sep; 5(5):379-85. PubMed ID: 12911848
    [No Abstract]   [Full Text] [Related]  

  • 14. Subgroup analyses of the major clinical endpoints in the Program on the Surgical Control of the Hyperlipidemias (POSCH): overall mortality, atherosclerotic coronary heart disease (ACHD) mortality, and ACHD mortality or myocardial infarction.
    Matts JP; Buchwald H; Fitch LL; Campos CT; Varco RL; Campbell GS; Pearce MB; Yellin AE; Smink RD; Sawin HS
    J Clin Epidemiol; 1995 Mar; 48(3):389-405. PubMed ID: 7897460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in dyslipidemia.
    Burke HB
    Heart Dis; 2002; 4(3):141-6. PubMed ID: 12028597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [KLAS [Kanazawa Lipid Assessment Survey]].
    Mabuchi H; Inazu A; Higashikata T; Nohara A; Koizumi J
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():469-76. PubMed ID: 11347115
    [No Abstract]   [Full Text] [Related]  

  • 17. [IV Brazilian Guideline for Dyslipidemia and Atherosclerosis prevention: Department of Atherosclerosis of Brazilian Society of Cardiology].
    Sposito AC; Caramelli B; Fonseca FA; Bertolami MC; Afiune Neto A; Souza AD; Lottenberg AM; Chacra AP; Faludi AA; Loures-Vale AA; Carvalho AC; Duncan B; Gelonese B; Polanczyk C; Rodrigues Sobrinho CR; Scherr C; Karla C; Armaganijan D; Moriguchi E; Saraiva F; Pichetti G; Xavier HT; Chaves H; Borges JL; Diament J; Guimarães JI; Nicolau JC; dos Santos JE; de Lima JJ; Vieira JL; Novazzi JP; Faria Neto JR; Torres KP; Pinto Lde A; Bricarello L; Bodanese LC; Introcaso L; Malachias MV; Izar MC; Magalhães ME; Schmidt MI; Scartezini M; Nobre M; Foppa M; Forti NA; Berwanger O; Gebara OC; Coelho OR; Maranhão RC; dos Santos Filho RD; Costa RP; Barreto S; Kaiser S; Ihara S; Carvalho Td; Martinez TL; Relvas WG; Salgado W;
    Arq Bras Cardiol; 2007 Apr; 88 Suppl 1():2-19. PubMed ID: 17515982
    [No Abstract]   [Full Text] [Related]  

  • 18. Overall mortality, incremental life expectancy, and cause of death at 25 years in the program on the surgical control of the hyperlipidemias.
    Buchwald H; Rudser KD; Williams SE; Michalek VN; Vagasky J; Connett JE
    Ann Surg; 2010 Jun; 251(6):1034-40. PubMed ID: 20485136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperlipidaemia and cardiovascular disease.
    Stone NJ
    Curr Opin Lipidol; 2001 Dec; 12(6):667-9. PubMed ID: 11801867
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of halofenate on serum lipids.
    Aronow WS; Harding PR; Khursheed M; Vangrow JS; Papageorge's NP; Mays J
    Clin Pharmacol Ther; 1973; 14(3):358-65. PubMed ID: 4572798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.